Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

mor growth inhibition in models of breast cancer, colorectal cancer, non-small cell lung cancer, and glioblastoma, and has been shown to cause substantial tumor regression in all models tested. Significantly, a single dose of XL880 completely inhibited tumor growth for 21 days in a glioblastoma model.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in Phase II and Phase I clinical development for cancer and renal disease. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Sankyo. For more information, please visit the company's web site at www.exelixis.com.

This press release contains forward-looking statements, including without limitation statements related to the potential efficacy of XL880. Words such as "suggest," "believes," "indicates," "should," and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Exelixis' current expectations. Forward-looking statements involve risks and uncertainties. Exelixis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the potential failure of XL880 to demonstrate safety and efficacy in clinical testing. These and other risk factors are discussed under "Risk Factors" and elsewhere in Exelixis'
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:7/30/2014)... , July 30, 2014   Medical Equipment Solutions, ... been awarded a Department of Defense (US Army) contract ... supply a mobile MRI diagnostic machine and technical support ... (WOSB) through the Small Business Administration (SBA), Medical Equipment ... field with the latest medical diagnostic equipment. The SBA ...
(Date:7/30/2014)... TAIPEI , 30. Juli 2014 /PRNewswire/ ... 4106), ein führender Anbieter im Bereich Atemtherapie- ... Urteil des Landgerichts München in Deutschland anfechten ... von bestimmten Masken ein Patent von ResMed ... Unternehmen in wichtigen Ländern gegen verschiedene Patente ...
(Date:7/29/2014)... Inc. (NASDAQ: SQNM ), a life sciences ... revenues of $39.8 million for the second quarter of ... $24.5 million for the second quarter of 2013. ... on May 30, 2014, has been accounted for as ... excluded from continuing operations for all periods. ...
Breaking Medicine Technology:Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 2Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 3Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 4Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 5Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 6Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 7Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 8Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 9Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 10Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 11Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 12Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 13Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 14Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 15Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 16
(Date:7/30/2014)... 30, 2014 Decene is an ... chain of ten carbon atoms with one double ... of 1-decenes. It can be used as a ... to produce epoxides, amines, oxo alcohols, synthetic lubricants, ... Early buyers will receive 10% customization on this ...
(Date:7/30/2014)... 2014 (HealthDay News) -- Medical costs for chronic obstructive ... than $32 billion each year, according to new research ... The yearly financial toll of COPD (which includes ... estimated $49 billion by 2020. "For the first ... provide state public health practitioners with estimates of the ...
(Date:7/30/2014)... The global digital pathology market was valued at an estimated ... a CAGR of 11.8%, to reach an estimated $437 million ... and is expected to continue to rise in the coming ... software enable pathologists to be efficient and this leads to ... American market was valued at $128.9 million and accounted for ...
(Date:7/30/2014)... (July 30, 2014) With the advent of non-surgical ... popular science and researchers must work to ensure ... of stroke rehabilitation. A new study out today ... shift in perspective and suggests that chronically stimulating ... promote stroke motor recovery, for example by restoring ...
(Date:7/30/2014)... Rhode Island Hospital researchers have found that ... significantly reduce depression and other symptoms in informal ... with dementia. The study is published online in ... & Dementia . , "Those caring for people ... are often under a great deal of pressure," ...
Breaking Medicine News(10 mins):Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Annual COPD Costs To Hit $49 Billion by 2020: CDC 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5Health News:Neuro researchers advocate for a shift in thinking for stroke rehabilitation 2Health News:Study: Telephone support program beneficial for caregivers of those with dementia 2
... a nationwide increase in the incidence of injuries as a ... researchers at the Johns Hopkins Bloomberg School of Public Health ... for injuries from lawn mowing which is regarded to be ... spring. , The research also pointed out to ...
... evaluate the safety of using the amalgam fillings that contain ... health risk in children // , bringing much respite not ... to foodconsumer.org. The studies were conducted independently, one in Europe ... same conclusion about the health risks of dental amalgam in ...
... health ministry of China has reported bird flu infection in a ... and pneumonia // on 1st April has been admitted to a ... confirms the presence of bird flu infection, it would mark the ... nation. ,Since 2003, nearly 194 people have been known ...
... Health officials declared on Tuesday in Guwahati that, at least ... northeast India and another 25,000 have fallen sick from the ... Assam state government announced that since the beginning of April, ... two districts in the eastern part of the state Lakhmipur ...
... study titled 'Search for Diabetes in Youth' has highlighted the ... points out to the importance of keeping a constant vigil ... prevent the associated complications. The results of the study have ... official journal of the Juvenile Diabetes Research Foundation. ...
... earn for meeting specific targets like children's vaccinations. While there ... ?250,000.// ,The elevation in GP’s pay is after the ... as GPs historically earned less than hospital doctors, and trainee ... the perceived high workload and a responsibility for 24-hour cover. ...
Cached Medicine News:Health News:Nationwide Increase In Lawn Mowing Injuries 2Health News:Dental Amalgam Doesn't Pose Health Risks In Children 2Health News:Dental Amalgam Doesn't Pose Health Risks In Children 3Health News:Dental Amalgam Doesn't Pose Health Risks In Children 4Health News:14% Of Pune Population Diabetic: Children Most Affected 2
... Nanopipetting System Genesis NPS based on the ... you to miniaturize your assays for high ... and direct dilutions., Furthermore it is ... including gene expression analysis, gene mapping, SNP ...
... is a reagent dispensing system designed to ... microplates. This dispenser can be equipped with ... orifice nozzle heads. Precise plate positioning and ... to a variety of plate types including ...
... Dispenses volumes down to 0.5ul for 384 ... less than 30 seconds per plate significantly ... user interface that provides one-button dispensing. It ... suspensions, beads, or cells, with high precision ...
... QFill2 is the ideal system for fast, accurate ... pressure driven, pinch valve controlled dispensing mechanism, ensures ... all of the components that come into contact ... clean, and autoclave. The unique compact design saves ...
Medicine Products: